Spots Global Cancer Trial Database for biweekly
Every month we try and update this database with for biweekly cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) | NCT00995761 | Non-small Cell ... | Docetaxel and C... | 18 Years - 75 Years | Gyeongsang National University Hospital | |
Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) | NCT00995761 | Non-small Cell ... | Docetaxel and C... | 18 Years - 75 Years | Gyeongsang National University Hospital | |
Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer | NCT02821559 | Metastatic Colo... | TOMOX Bevacizumab | 18 Years - 80 Years | Centre Hospitalier Universitaire de Besancon | |
Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer | NCT02821559 | Metastatic Colo... | TOMOX Bevacizumab | 18 Years - 80 Years | Centre Hospitalier Universitaire de Besancon |